The Norman Transcript1d
Injectable weight-loss drugs increasing calls to state poison center
The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs ...
'I'm a pharmacist - worrying rise in patients needing organ removed with weight loss jabs'
Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...
How to Lose Face Fat (Without Going Under the Knife)
I cringe when I see people doing the buccal fat removal surgery,” says one A-list esthetician. Here’s what you can do instead ...
Pharmacist's urgent warning over painful skinny jab side effect
Deborah Grayson, who is also a nutritional therapist, says weight-loss injection companies will have to update their ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Scientists develop yearly HIV injection: How it could help millions
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Six simple shop swaps that can help you lose weight
This week has been full of bad news for our health, with headlines about weight loss injections, childhood obesity and ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
STAT4d
Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...
Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...
Roche takes big step in weight-loss field with $5.3 billion deal.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement.